{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T04:16:22Z","timestamp":1778991382052,"version":"3.51.4"},"reference-count":64,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Although uremic osteoporosis is a component of mineral and bone disorder in chronic kidney disease, uremic toxin (UT) concentrations in patients with end-stage kidney disease and bone mineral density (BMD) changes after kidney transplantation have not previously been described. We hypothesized that elevated UT concentrations at the time of transplantation could have a negative impact on bone during the early post-transplantation period. Hence, we sought to determine whether concentrations of UTs (trimethylamine-N-oxide, indoxylsulfate, p-cresylsulfate, p-cresylglucuronide, indole-3-acetic acid, hippuric acid, and 3-carboxy-4-methyl-5-propyl-furanpropionic acid) upon transplantation are predictive markers for (i) osteoporosis one month after transplantation, and (ii) a BMD decrease and the occurrence of fractures 12 and 24 months after kidney transplantation. Between 2012 and 2018, 310 kidney transplant recipients were included, and dual-energy X-ray absorptiometry was performed 1, 12, and 24 months after transplantation. The UT concentrations upon transplantation were determined by reverse-phase high-performance liquid chromatography. Indoxylsulfate concentrations upon transplantation were positively correlated with BMD one month after transplantation for the femoral neck but were not associated with osteoporosis status upon transplantation. Concentrations of the other UTs upon transplantation were not associated with osteoporosis or BMD one month after transplantation. None of the UT concentrations were associated with BMD changes and the occurrence of osteoporotic fractures 12 and 24 months after transplantation. Hence, UT concentrations at the time of kidney transplantation were not predictive markers of osteoporosis or fractures.<\/jats:p>","DOI":"10.3390\/toxins12110715","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T08:44:02Z","timestamp":1605257042000},"page":"715","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between Uremic Toxin Concentrations and Bone Mineral Density after Kidney Transplantation"],"prefix":"10.3390","volume":"12","author":[{"given":"Benjamin","family":"Batteux","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Amiens University Medical Center, F-80000 Amiens, France"},{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie, F-80000 Amiens, France"},{"name":"Department of Rheumatology, Saint-Quentin Medical Center, F-02321 Amiens, France"},{"name":"RECIF, Amiens University Medical Center, F-80000 Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Bodeau","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Amiens University Medical Center, F-80000 Amiens, France"},{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie, F-80000 Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Andr\u00e9","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Amiens University Medical Center, F-80000 Amiens, France"},{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie, F-80000 Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Sophie","family":"Hurtel-Lemaire","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Amiens University Medical Center, F-80000 Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Gras-Champel","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Amiens University Medical Center, F-80000 Amiens, France"},{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie, F-80000 Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Desailly-Henry","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amiens University Medical Center, F-80000 Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamel","family":"Masmoudi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Amiens University Medical Center, F-80000 Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0186-4797","authenticated-orcid":false,"given":"Youssef","family":"Bennis","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Amiens University Medical Center, F-80000 Amiens, France"},{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie, F-80000 Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad A.","family":"Massy","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ambroise Par\u00e9 University Hospital, APHP, Boulogne Billancourt, F-92100 Paris, France"},{"name":"Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Universit\u00e9 Paris-Saclay, F-94807 Villejuif, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u00efd","family":"Kamel","sequence":"additional","affiliation":[{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie, F-80000 Amiens, France"},{"name":"Biochemistry Laboratory, Amiens University Medical Center, F-80000 Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Choukroun","sequence":"additional","affiliation":[{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie, F-80000 Amiens, France"},{"name":"Department of Nephrology Internal Medicine Dialysis Transplantation, Amiens University Medical Center, F-80000 Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5384-9006","authenticated-orcid":false,"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Amiens University Medical Center, F-80000 Amiens, France"},{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie, F-80000 Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/nep.13457","article-title":"Mineral bone disorders in chronic kidney disease","volume":"23","author":"Hou","year":"2018","journal-title":"Nephrology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem-67-5-876","article-title":"Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure","volume":"67","author":"Pitts","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/11.supp3.29","article-title":"The aplastic form of renal osteodystrophy","volume":"11","author":"Sherrard","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_5","first-page":"117","article-title":"Adynamic bone disease: An update and overview","volume":"18","author":"Coen","year":"2005","journal-title":"J. Nephrol."},{"key":"ref_6","first-page":"115","article-title":"Bone Mineral Density in Patients with End-Stage Renal Failure","volume":"13","author":"Gabay","year":"1993","journal-title":"AJN"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/0971-4065.82140","article-title":"Bone mineral density in patients with end-stage renal disease and its evolution after kidney transplantation","volume":"21","author":"Govindarajan","year":"2011","journal-title":"Indian J. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.5650090102","article-title":"Changes in bone mass early after kidney transplantation","volume":"9","author":"Horber","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","article-title":"Rapid loss of vertebral mineral density after renal transplantation","volume":"325","author":"Julian","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1759720X20953357","DOI":"10.1177\/1759720X20953357","article-title":"Early steroid withdrawal has a positive effect on bone in kidney transplant recipients: A propensity score study with inverse probability-of-treatment weighting","volume":"12","author":"Batteux","year":"2020","journal-title":"Ther. Adv. Musculoskelet Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5301\/jn.5000015","article-title":"Determinants of bone mineral density in stable kidney transplant recipients","volume":"25","author":"Gupta","year":"2012","journal-title":"J. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1016\/j.transproceed.2010.07.106","article-title":"Loss of bone mineral density in renal transplantation recipients","volume":"42","author":"Unal","year":"2010","journal-title":"Transplant. Proc."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kitamura, M., Mochizuki, Y., Miyata, Y., Obata, Y., Mitsunari, K., Matsuo, T., Ohba, K., Mukae, H., Yoshimura, A., and Nishino, T. (2019). Pathological Characteristics of Periodontal Disease in Patients with Chronic Kidney Disease and Kidney Transplantation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143413"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/10454411980090030101","article-title":"Cytokine expression in periodontal health and disease","volume":"9","author":"Okada","year":"1998","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2220\/biomedres.32.343","article-title":"Relationships between periodontal inflammation, lipid peroxide and oxidative damage of multiple organs in rats","volume":"32","author":"Tomofuji","year":"2011","journal-title":"Biomed. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/odi.12180","article-title":"Differential expression of transglutaminase genes in patients with chronic periodontitis","volume":"20","author":"Matarese","year":"2014","journal-title":"Oral Dis."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Isola, G., Alibrandi, A., Curr\u00f2, M., Matarese, M., Ricca, S., Matarese, G., Ientile, R., and Kocher, T. (2020). Evaluation of salivary and serum ADMA levels in patients with periodontal and cardiovascular disease as subclinical marker of cardiovascular risk. J. Periodontol.","DOI":"10.1002\/JPER.19-0446"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","article-title":"Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"(2017). Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl. (2011), 7, 1\u201359.","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Khairallah, P., Nickolas, T.L., and Fusaro, M. (2019). How and when to assess bone mineral density and bone quality in chronic kidney disease patients?. Nephrol. Dial. Transplant.","DOI":"10.1093\/ndt\/gfz198"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40620-017-0406-x","article-title":"Uremic Toxicity and Bone in CKD","volume":"30","author":"Yamamoto","year":"2017","journal-title":"J. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Liabeuf, S., Cheddani, L., and Massy, Z.A. (2018). Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation. Toxins, 10.","DOI":"10.3390\/toxins10060229"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1253\/circj.CJ-15-0949","article-title":"Levels of Indoxyl Sulfate in Kidney Transplant Patients, and the Relationship with Hard Outcomes","volume":"80","author":"Liabeuf","year":"2016","journal-title":"Circ. J."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Liabeuf, S., Laville, S.M., Glorieux, G., Cheddani, L., Brazier, F., Titeca Beauport, D., Valholder, R., Choukroun, G., and Massy, Z.A. (2020). Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062031"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/ndt\/gfw009","article-title":"The influence of renal transplantation on retained microbial-human co-metabolites","volume":"31","author":"Poesen","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/ndt\/gfp592","article-title":"Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease","volume":"25","author":"Liabeuf","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lekawanvijit, S. (2018). Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome. Toxins, 10.","DOI":"10.3390\/toxins10090352"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Iwasaki","year":"2007","journal-title":"Kidney Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/2211-5463.12258","article-title":"Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption","volume":"7","author":"Watanabe","year":"2017","journal-title":"FEBS Open Bio"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bone.2013.07.002","article-title":"p-Cresyl sulfate induces osteoblast dysfunction through activating JNK and p38 MAPK pathways","volume":"56","author":"Tanaka","year":"2013","journal-title":"Bone"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4158\/EP12059.RA","article-title":"Secondary causes of osteoporosis","volume":"19","author":"Hudec","year":"2013","journal-title":"Endocr. Pract."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00216-012-6636-9","article-title":"A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients","volume":"405","author":"Boelaert","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1681\/ASN.2014111063","article-title":"Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden","volume":"27","author":"Stubbs","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ki.1976.42","article-title":"Bone histology in incipient and advanced renal failure","volume":"9","author":"Malluche","year":"1976","journal-title":"Kidney Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1046\/j.1523-1755.2000.00306.x","article-title":"Down-regulation of human osteoblast PTH\/PTHrP receptor mRNA in end-stage renal failure","volume":"58","author":"Picton","year":"2000","journal-title":"Kidney Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.ndt.a027404","article-title":"Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: A cross-sectional study","volume":"11","author":"Coen","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1002\/JPER.18-0006","article-title":"Staging and grading of periodontitis: Framework and proposal of a new classification and case definition","volume":"89","author":"Tonetti","year":"2018","journal-title":"J. Periodontol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ki.2010.384","article-title":"Bidirectional relationship between chronic kidney and periodontal disease: A study using structural equation modeling","volume":"79","author":"Fisher","year":"2011","journal-title":"Kidney Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nri3785","article-title":"Periodontitis: From microbial immune subversion to systemic inflammation","volume":"15","author":"Hajishengallis","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000096411","article-title":"Antibodies to periodontal organisms are associated with decreased kidney function. The Dental Atherosclerosis Risk in Communities study","volume":"25","author":"Kshirsagar","year":"2007","journal-title":"Blood Purif."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000046994","article-title":"Importance of periodontal disease in the kidney patient","volume":"20","author":"Craig","year":"2002","journal-title":"Blood Purif."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.kint.2016.08.025","article-title":"Progression of chronic kidney disease: Too much cellular talk causes damage","volume":"91","author":"Gewin","year":"2017","journal-title":"Kidney Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.yexcr.2018.02.022","article-title":"Chronic kidney disease induces inflammation by increasing Toll-like receptor-4, cytokine and cathelicidin expression in neutrophils and monocytes","volume":"365","author":"Grabulosa","year":"2018","journal-title":"Exp. Cell Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"9179632","DOI":"10.1155\/2016\/9179632","article-title":"Salivary Markers for Periodontal and General Diseases","volume":"2016","author":"Podzimek","year":"2016","journal-title":"Dis. Markers"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11657-019-0643-9","article-title":"An investigation of the bidirectional link between osteoporosis and periodontitis","volume":"14","author":"Penoni","year":"2019","journal-title":"Arch. Osteoporos."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11914-016-0330-3","article-title":"Osteoporosis and Periodontitis","volume":"14","author":"Wang","year":"2016","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1902\/jop.1996.67.10s.1076","article-title":"The role of osteopenia in oral bone loss and periodontal disease","volume":"67","author":"Grossi","year":"1996","journal-title":"J. Periodontol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Kitaura, H., Marahleh, A., Ohori, F., Noguchi, T., Shen, W.-R., Qi, J., Nara, Y., Pramusita, A., Kinjo, R., and Mizoguchi, I. (2020). Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21145169"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Pyo, J., Lee, M., Ock, M., and Lee, J. (2020). Quality of Life and Health in Patients with Chronic Periodontitis: A Qualitative Study. Int. J. Environ. Res. Public Health, 17.","DOI":"10.21203\/rs.2.22479\/v1"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/jcpe.13233","article-title":"Periodontitis is associated with oral health-related quality of life in individuals with end-stage renal disease","volume":"47","author":"Oliveira","year":"2020","journal-title":"J. Clin. Periodontol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa063186","article-title":"Treatment of periodontitis and endothelial function","volume":"356","author":"Tonetti","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/jcpe.12067","article-title":"Periodontitis and chronic kidney disease: A systematic review of the association of diseases and the effect of periodontal treatment on estimated glomerular filtration rate","volume":"40","author":"Chambrone","year":"2013","journal-title":"J. Clin. Periodontol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40620-015-0195-z","article-title":"Association of advanced age with concentrations of uraemic toxins in CKD","volume":"29","author":"Rroji","year":"2016","journal-title":"J. Nephrol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: A systematic review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Six, I., Flissi, N., Lenglet, G., Louvet, L., Kamel, S., Gallet, M., Massy, Z.A., and Liabeuf, S. (2020). Uremic Toxins and Vascular Dysfunction. Toxins, 12.","DOI":"10.3390\/toxins12060404"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/ndt\/gfl311","article-title":"Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats","volume":"21","author":"Iwasaki","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5935\/0101-2800.20140042","article-title":"Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients","volume":"36","author":"Barreto","year":"2014","journal-title":"J. Bras. Nefrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1046\/j.1523-1755.2001.0600031182.x","article-title":"Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia","volume":"60","author":"Green","year":"2001","journal-title":"Kidney Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrneph.2015.153","article-title":"Phosphate and FGF-23 homeostasis after kidney transplantation","volume":"11","author":"Baia","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_63","first-page":"32","article-title":"Management of adynamic bone disease in chronic kidney disease: A brief review","volume":"5","author":"Sista","year":"2016","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"122234","DOI":"10.1016\/j.jchromb.2020.122234","article-title":"Two rapid, accurate liquid chromatography tandem mass spectrometry methods for the quantification of seven uremic toxins: An application for describing their accumulation kinetic profile in a context of acute kidney injury","volume":"1152","author":"Bennis","year":"2020","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/11\/715\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:32:52Z","timestamp":1760178772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/11\/715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":64,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["toxins12110715"],"URL":"https:\/\/doi.org\/10.3390\/toxins12110715","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]}}}